Tourniquets do not increase the total blood loss or re-amputation risk in transtibial amputations

Table 1 Demographic of the included patients

Variables	All patients n = 74	Tourniquet group n = 38	Non-tourniquet n = 36	P value
Sex (female/male)	25/49	11/27	14/22	0.511
Age (yr)	72.3 ± 11.0	71.3 ± 9.8	73.4 ± 12.1	0.415
Height (cm)	172 ± 9	173 ± 9	171 ± 9	0.178
Weight (kg)	74.2 ± 18.8	78.2 ± 18.6	70.1 ± 18.4	0.065
Body mass index	25.0 ± 5.4	25.9 ± 5.5	23.9 ± 5.2	0.112
Cause of amputation (diabetes/arteriosclerosis)	39/35	19/19	20/16	0.806
ASA group 1-2/3-4	13/60	5/32	8/28	0.374
Rank of surgeon, (resident/consultant)	49/25	24/14	25/11	0.745
Preoperative hemoglobin (g/dL)	10.9 ± 1.6	11.2 ± 1.6	10.8 ± 1.4	0.246
Preoperative Thrombocyte (× 109/L)	368 ± 150	352 ± 121	380 ± 169	0.481
NSAID or acetylsalicylic acid (yes/no)	40/34	20/18	20/16	0.985
Clopidogrel (yes/no)	14/60	8/30	6/30	0.854

Data are presented as numbers or mean values with standard deviations. ASA: American Society of anesthesiologists; NSAID: Nonsteroidal anti-inflammatory drug.